More Than a Bean: The Unexpected Everyday Triggers That Can Spark a G6PD Hemolytic Crisis

Ask most people what they know about G6PD deficiency and the answer is almost always the same: "You can't eat fava beans." That association is accurate—fava beans contain vicine and convicine, compounds that generate oxidative stress capable of overwhelming the already-compromised antioxidant capacity of G6PD-deficient red blood cells. But reducing G6PD management to a single dietary restriction gives patients a dangerously incomplete picture.

Hemolytic crises—episodes in which red blood cells are destroyed faster than the body can replace them—can be triggered by a wide range of exposures that many patients and even some clinicians have never considered. This guide is designed to fill that gap, providing a detailed, practical reference for individuals managing G6PD deficiency in everyday American life.

How Oxidative Stress Destroys Red Blood Cells

Before examining specific triggers, it helps to understand the underlying mechanism. G6PD is an enzyme that plays a critical role in the pentose phosphate pathway, a metabolic route that produces NADPH—a molecule essential for neutralizing reactive oxygen species (free radicals) inside red blood cells. When G6PD activity is deficient, the cell's ability to manage oxidative stress is impaired. Certain substances dramatically increase the production of free radicals, overwhelming the cell's defenses and causing the hemoglobin inside to denature. The result is hemolysis: the premature rupture of red blood cells.

With that mechanism in mind, the following triggers make biochemical sense—even when they seem surprising on the surface.

Infections: The Most Overlooked Trigger

For many patients with G6PD deficiency, hemolytic episodes are not caused by a specific food or medication—they are caused by an infection. Bacterial and viral illnesses generate significant systemic oxidative stress as the immune system mounts its response. This inflammatory environment can be sufficient to trigger hemolysis in G6PD-deficient individuals, even without any additional exposures.

Common infections associated with hemolytic episodes include influenza, COVID-19, hepatitis A and B, pneumonia, and urinary tract infections. In some cases, the hemolysis is misattributed to a medication prescribed to treat the infection rather than to the infection itself—a confusion that can delay accurate diagnosis.

Practical guidance: Annual influenza vaccination and staying current on recommended vaccines (including hepatitis A and B) reduces the likelihood of infection-related triggers. During any illness, patients should monitor for symptoms of hemolysis—unusual fatigue, pallor, dark urine, or rapid heart rate—and contact a healthcare provider promptly.

Naphthalene: The Danger in the Closet

Mothballs containing naphthalene are a well-documented but widely underappreciated hazard for G6PD-deficient individuals. Naphthalene is a potent oxidant, and exposure—particularly inhalation of vapors in enclosed spaces—can trigger severe hemolytic anemia. Cases have been reported in infants and children whose bedding or clothing was stored with naphthalene mothballs.

In the United States, naphthalene mothballs remain legally available and are commonly found in homes, particularly in older households. Cedar alternatives and synthetic repellent products do not carry the same risk.

Practical guidance: Remove all naphthalene-containing products from your home and replace them with cedar blocks or lavender sachets. When moving into a new residence or handling stored items from another household, be alert to the distinctive sharp odor of naphthalene.

Certain Dietary Supplements and Herbal Products

The supplement industry operates with considerably less regulatory oversight than the pharmaceutical industry, which means that products marketed as "natural" or "beneficial" may contain compounds problematic for G6PD-deficient individuals. Several commonly used supplements warrant particular attention.

Vitamin C (ascorbic acid) in high doses: While small amounts of dietary vitamin C are generally well tolerated, high-dose supplementation—particularly intravenous formulations used in some integrative medicine settings—has been associated with hemolysis in G6PD-deficient patients. Standard dietary intake from food sources is unlikely to pose significant risk.

Vitamin K (menadione): The synthetic form of vitamin K, menadione (vitamin K3), is an oxidant and should be avoided. Note that vitamin K1 (phylloquinone), found in leafy green vegetables and used in standard clinical settings, is generally considered safe.

Alpha-lipoic acid: This antioxidant supplement, popular for its purported metabolic benefits, has been reported to cause hemolytic episodes in some G6PD-deficient individuals. The mechanism is not fully elucidated, but caution is warranted.

Herbal products containing tannins or quinones: Several traditional herbal remedies—including henna (when ingested or used extensively on broken skin), certain Chinese herbal formulations, and products containing rauwolfia—have been implicated in hemolytic episodes.

Practical guidance: Before beginning any new supplement or herbal product, consult a pharmacist or physician familiar with G6PD deficiency. The G6PD Deficiency Association maintains an updated list of substances of concern that patients can use as a reference.

Food Dyes and Artificial Additives

The evidence base here is less robust than for medications or infections, but several artificial food colorings—particularly FD&C Blue No. 1 (brilliant blue) and certain synthetic dyes used in beverages, candies, and processed foods—have been flagged in case reports and small studies as potential triggers in highly sensitive individuals.

This is an area where individual variation matters significantly. G6PD deficiency encompasses multiple genetic variants with differing levels of enzyme activity, and individuals with more severe deficiency (Class I and Class II variants) may be more susceptible to lower-level oxidative stressors than those with milder forms.

Practical guidance: While a strict elimination of all artificial dyes is not universally recommended, patients with severe G6PD deficiency may benefit from minimizing processed foods with high synthetic dye content as a precautionary measure.

Occupational Chemical Exposures

The workplace is a frequently overlooked source of G6PD triggers. Several industrial and agricultural chemicals are known oxidants that can precipitate hemolysis with repeated or acute exposure.

Aniline dyes and nitrobenzene compounds: Workers in textile manufacturing, chemical processing, and certain printing industries may encounter these substances. Inhalation or dermal absorption is sufficient to cause oxidative stress.

Dapsone and other aromatic amines: Some occupational settings involve exposure to compounds chemically similar to medications known to trigger G6PD crises. Workers in pharmaceutical manufacturing or pesticide application may be at elevated risk.

Chlorine compounds: High-level exposure to chlorine-based industrial chemicals—distinct from the trace chlorine in municipal water supplies—has been associated with hemolytic risk.

Practical guidance: G6PD-deficient workers in high-risk industries should disclose their diagnosis to occupational health services and request a workplace exposure assessment. Appropriate personal protective equipment and ventilation can substantially reduce risk.

Extreme Physical and Emotional Stress

Severe physical stress—including extreme exertion, surgical procedures, or significant trauma—can generate enough systemic oxidative burden to trigger hemolysis in susceptible individuals. Emotional stress, through its effects on cortisol and inflammatory signaling, may also play a contributing role, though the evidence is less direct.

Patients scheduled for elective surgery should inform their surgical team of their G6PD diagnosis prior to any procedure, as certain anesthetic agents and perioperative medications carry hemolytic risk.

Practical guidance: Carry a medical alert card or wear a medical identification bracelet indicating your G6PD diagnosis. Ensure that any physician prescribing medications in an emergency or surgical context is aware of your condition.

Building Your Personal Trigger Reference

No two patients with G6PD deficiency will have an identical experience. Variant type, overall health status, and individual metabolic factors all influence how a person responds to a given exposure. What triggers a severe episode in one patient may be tolerated without incident by another.

This variability makes personalized record-keeping essential. Maintaining a detailed log of any suspected hemolytic episodes—including dates, symptoms, recent exposures, medications, illnesses, and foods consumed—creates an invaluable clinical document that can help both patients and their physicians identify individual patterns and refine avoidance strategies over time.

G6PD Awareness is committed to providing patients with the comprehensive, evidence-informed resources they need to manage this condition safely. Understanding the full scope of potential triggers—not just the ones that appear on a standard patient handout—is a cornerstone of that mission. Knowledge, rigorously applied, is the most reliable protection available.